Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bupivacaine hydrochloride + povidone-iodine + methylprednisolone acetate
- Development stage
- Unknown
- Lead developer
- Proficient Rx
- Modality
- Small Molecules
- Administration
- Injection, Topical
01
Overview
bupivacaine hydrochloride + povidone-iodine + methylprednisolone acetate is a combination pharmaceutical kit product marketed as **PHYSICIANS EZ USE M-PRED**. It combines **bupivacaine hydrochloride**, an amide local anesthetic that blocks voltage-gated sodium channel-mediated nerve impulse initiation and conduction to provide local or regional analgesia/anesthesia; **methylprednisolone acetate**, a depot glucocorticoid anti-inflammatory used for intramuscular, intra-articular, soft tissue, or intralesional injection; and **povidone-iodine**, an iodophor antiseptic used for skin antisepsis. Based on the provided context, the product is packaged for clinical procedural use where local anesthesia/analgesia, anti-inflammatory steroid injection, and antiseptic preparation are used together.
- Brand names
- PHYSICIANS EZ USE M-PRED
- Other names
- bupivacaine hydrochloride + povidone-iodine + methylprednisolone acetate
02
Targets
NaV (Voltage-gated sodium channels)PTGER1 (Prostaglandin E Receptor 1)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)KCNA5 (Ultra-rapid delayed rectifier potassium channel)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on bupivacaine hydrochloride + povidone-iodine + methylprednisolone acetate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bupivacaine hydrochloride + povidone-iodine + methylprednisolone acetate.